Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/12990
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorBarber Hernández, Domingo-
dc.creatorEscribese Alonso, María Marta-
dc.creatorGómez Casado, Cristina-
dc.creatorVillaseñor Solis, Alma Cristina-
dc.date2019-
dc.date.accessioned2021-09-14T04:00:13Z-
dc.date.available2021-09-14T04:00:13Z-
dc.date.issued2019-09-14-
dc.identifier000000723492-
dc.identifier.urihttp://hdl.handle.net/10637/12990-
dc.descriptionArtículo en colaboración con: Alma Villaseñor; Alba Rodriguez Nogales; Jose Luis Bueno; Domingo Barber; Maria M. Escribese.-
dc.descriptionEn: International Journal of Molecular Sciences. e-ISSN 1422-0067 2019, 20 - 7, pp. 1 - 18-
dc.description.abstractEmerging evidence suggests that platelets, cytoplasmic fragments derived from megakaryocytes, can no longer be considered just as mediators in hemostasis and coagulation processes, but as key modulators of immunity. Platelets have received increasing attention as the emergence of new methodologies has allowed the characterization of their components and functions in the immune continuum. Platelet activation in infectious and allergic lung diseases has been well documented and associated with bacterial infections reproduced in several animal models of pulmonary bacterial infections. Direct interactions between platelets and bacteria have been associated with increased pulmonary platelet accumulation, whereas bacterial-derived toxins have also been reported to modulate platelet function. Recently, platelets have been found extravascular in the lungs of patients with asthma, and in animal models of allergic lung inflammation. Their ability to interact with immune and endothelial cells and secrete immune mediators makes them one attractive target for biomarker identification that will help characterize their contribution to lung diseases. Here, we present an original review of the last advances in the platelet field with a focus on the contribution of platelets to respiratory infections and allergic-mediated diseases.en-EN
dc.formatapplication/pdf-
dc.language.isoen-
dc.relationThis work is supported by ISCIII (Project numbers PI15/02256, PI16/00249 and PI18/01467) co-funded by the European Regional Development Fund “Investing in your future” for the thematic network and co-operative research centers ARADyAL RD16/0006/0015, RD16/0006/0001. C.G.-C. is supported by a postdoctoral contract co-funded by the competitive Program “Attracting Talent”, Community of Madrid, Spain.en-EN
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.es-
dc.subjectPlateletsen-EN
dc.subjectMediatorsen-EN
dc.subjectAllergic inflammationen-EN
dc.subjectInfectious diseaseen-EN
dc.titleUnderstanding platelets in infectious and allergic lung diseases.-
dc.typeArtículo-
dc.identifier.doi10.3390/ijms20071730-
dc.centroUniversidad San Pablo-CEU-
Aparece en las colecciones: Facultad de Farmacia




Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.